Limbach
Limbach's revenue rose 24.7% to $647 million in fiscal 2025. Its operating margin was 7.7%, up from 7.5% a year earlier. Free cash flow was $42 million, up 43.2%. The diluted share count rose 0.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
From fiscal 2020 to 2025, earnings per share grew 35.0% a year and net income 46.5% a year, as new shares raised the share count by 49% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 14 | 36 | 60 | 45 | 11 |
| Debt incl. finance leases | 45 | 31 | 22 | 27 | 36 |
| Net debt (negative means net cash) | 30 | −5 | −38 | −18 | 24 |
| Net debt to EBITDA | 1.5x | −0.2x | −1.0x | −0.4x | 0.4x |
| Debt to equity | 0.5x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 5.5x | 5.6x | 14.3x | 20.7x | 15.8x |
| Current ratio | 1.5x | 1.4x | 1.5x | 1.5x | 1.4x |
| Quick ratio | 1.5x | 1.4x | 1.5x | 1.5x | 1.4x |
Cash flow
Projections
Project Limbach's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 3 insiders bought $515,933 of Limbach shares on the open market, and 2 insiders sold $3.1 million, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Jay SharpExecutive Vice President | Sold plan | 5,094 | $50.21 | $255,770 | Form 4 |
| Sep 15, 2026 | Palm Global Small Cap Master Fund LPDirector Affiliate | Bought | 4,220 | $50.71 | $214,008 | Form 4 |
| Sep 15, 2026 | Laurel J KrzeminskiDirector | Bought | 500 | $50.58 | $25,290 | Form 4 |
| Sep 14, 2026 | David Richard GabouryDirector | Bought | 1,940 | $51.35 | $99,619 | Form 4 |
| Sep 11, 2026 | Palm Global Small Cap Master Fund LPDirector Affiliate | Bought | 3,600 | $49.17 | $177,016 | Form 4 |
| Jun 15, 2026 | Jay SharpExecutive Vice President | Sold plan | 4,871 | $79.82 | $388,803 | Form 4 |
| Apr 30, 2026 | Jayme L. BrooksChief Financial Officer | Sold plan | 3,440 | $100.00 | $344,000 | Form 4 |
| Apr 24, 2026 | Jayme L. BrooksChief Financial Officer | Sold plan | 2,173 | $100.05 | $217,409 | Form 4 |
| Apr 13, 2026 | Jayme L. BrooksChief Financial Officer | Sold plan | 5,703 | $85.43 | $487,207 | Form 4 |
| Apr 9, 2026 | Jayme L. BrooksChief Financial Officer | Sold plan | 841 | $85.11 | $71,578 | Form 4 |
| Apr 8, 2026 | Jayme L. BrooksChief Financial Officer | Sold plan | 3,366 | $85.19 | $286,750 | Form 4 |
| Mar 17, 2026 | Jayme L. BrooksChief Financial Officer | Sold plan | 9,910 | $78.56 | $778,531 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 7 of 9 | 5 of 9 | 5 of 9 |
| Rule of 40 | 14.6% | 6.1% | 31.1% |
| Altman Z'' | 3.21 | 3.41 | 3.87 |
| Accruals ratio | −12.2% | −1.8% | −1.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 7 of 9 | 5 of 9 | 5 of 9 |
Compare
Put Limbach side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Limbach | FY25 | 24.7% | 7.7% | 6.5% | 22.4% | 0.4x | 5 | |
| Willdan Group | FY25 | 20.5% | 6.5% | 10.4% | 16.3% | −0.2x | 7 | Compare |
| Southland | FY25 | −21.2% | −28.1% | 1.6% | −69.3% | — | 3 | Compare |
| Shimmick | FY25 | 2.6% | −3.9% | −14.5% | — | — | 4 | Compare |
| Orion Group | FY25 | 7.0% | 1.7% | −1.3% | 7.2% | 0.7x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | — | 486 | 546 | 553 | 568 | 490 | 497 | 516 | 519 | 647 |
| Revenue growth | — | — | 12.5% | 1.2% | 2.7% | −13.7% | 1.3% | 3.9% | 0.5% | 24.7% |
| Gross profit | — | 66 | 59 | 72 | 81 | 86 | 94 | 119 | 144 | 169 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | 6 | 1 | 8 | 17 | 14 | 12 | 29 | 39 | 50 |
| Net income | — | 1 | −2 | −2 | 6 | 7 | 7 | 21 | 31 | 39 |
| Diluted EPS (US$) | — | −0.13 | −0.52 | −0.23 | 0.72 | 0.66 | 0.64 | 1.76 | 2.57 | 3.23 |
| Diluted shares (millions) | — | 8 | 8 | 8 | 8 | 10 | 11 | 12 | 12 | 12 |
| Cash flow | ||||||||||
| Cash from operations | — | −4 | 25 | −1 | 40 | −24 | 35 | 57 | 37 | 46 |
| Capital expenditure | — | 3 | 4 | 3 | 2 | 1 | 1 | 2 | 8 | 4 |
| Free cash flow | — | −7 | 21 | −4 | 38 | −25 | 34 | 55 | 29 | 42 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 19 | 0 | 0 | 0 | 0 |
| Stock-based compensation | — | 2 | 2 | 2 | 1 | 3 | 3 | 5 | 6 | 7 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 7 | 1 | 2 | 8 | 42 | 14 | 36 | 60 | 45 | 11 |
| Debt incl. finance leases | 26 | 27 | 27 | 54 | 50 | 45 | 31 | 22 | 27 | 36 |
| Total assets | 207 | 213 | 254 | 262 | 262 | 268 | 295 | 304 | 352 | 381 |
| Total liabilities | 149 | 157 | 207 | 215 | 208 | 180 | 199 | 184 | 199 | 186 |
| Shareholders' equity | 47 | 48 | 46 | 47 | 54 | 88 | 95 | 121 | 154 | 196 |
| Margins and ratios | ||||||||||
| Gross margin | — | 13.5% | 10.9% | 13.0% | 14.3% | 17.5% | 18.9% | 23.1% | 27.8% | 26.2% |
| Operating margin | — | 1.2% | 0.2% | 1.5% | 3.0% | 2.9% | 2.4% | 5.7% | 7.5% | 7.7% |
| Net margin | — | 0.1% | −0.3% | −0.3% | 1.0% | 1.4% | 1.4% | 4.0% | 6.0% | 6.0% |
| Free cash flow margin | — | −1.5% | 3.9% | −0.7% | 6.8% | −5.1% | 6.9% | 10.7% | 5.6% | 6.5% |
| Rule of 40 (growth + FCF margin) | — | — | 16.4% | 0.6% | 9.4% | −18.8% | 8.2% | 14.6% | 6.1% | 31.1% |
| Return on capital | — | 4.3% | 1.1% | 7.7% | 18.5% | 11.1% | 8.1% | 24.9% | 27.3% | 22.4% |
| Return on equity | — | 1.5% | −3.9% | −3.8% | 11.5% | 9.5% | 7.4% | 19.2% | 22.5% | 22.4% |
| Return on assets | — | 0.3% | −0.8% | −0.7% | 2.2% | 2.5% | 2.4% | 6.9% | 9.4% | 10.7% |
| Net debt to EBITDA | — | 1.8x | 3.8x | 3.2x | 0.3x | 1.5x | −0.2x | −1.0x | −0.4x | 0.4x |